Free Trial
NASDAQ:HTFL

Heartflow Q3 2026 Earnings Date & Estimates

Heartflow logo
$59.92 +0.82 (+1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$58.30 -1.62 (-2.70%)
As of 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Heartflow is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes

What Analysts Expect from Heartflow in Q3 2026

Heartflow is expected to post earnings of -$0.18 per share. Heartflow last reported on August 13, 2026, posting -$0.07 per share and beating the -$0.22 consensus estimate.

Consensus Estimates

Consensus EPS
-$0.18

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.07 (Beat by +$0.15)
Last Quarter Revenue
$64.08 million

Heartflow Q3 2026 Earnings FAQ

Heartflow (NASDAQ:HTFL) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Heartflow to post earnings of -$0.18 per share for Q3 2026.

Heartflow Earnings Headlines

HeartFlow Q3 2026 earnings preview
HeartFlow Inc (HTFL) Q3 2026 Earnings Report Preview: What to Look For
This is likely to EXPLODE
Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.tc pixel
Contrasting Heartflow (NASDAQ:HTFL) & Evolent Health (NYSE:EVH)
HeartFlow (HTFL) Shares Moved, What Is Behind The Attention?
See More Heartflow Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heartflow? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heartflow and other key companies, straight to your email.

About Heartflow

Heartflow (NASDAQ:HTFL) is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning.

The company’s offerings include HeartFlow FFRCT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Founded in 2007, HeartFlow is headquartered in Mountain View, California, and serves healthcare providers in the United States and international markets. Its products are intended to complement clinical judgment and other diagnostic information.

View Heartflow Profile